247 related articles for article (PubMed ID: 22464073)
1. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
[TBL] [Abstract][Full Text] [Related]
4. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
5. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.
Norton ME; Brar H; Weiss J; Karimi A; Laurent LC; Caughey AB; Rodriguez MH; Williams J; Mitchell ME; Adair CD; Lee H; Jacobsson B; Tomlinson MW; Oepkes D; Hollemon D; Sparks AB; Oliphant A; Song K
Am J Obstet Gynecol; 2012 Aug; 207(2):137.e1-8. PubMed ID: 22742782
[TBL] [Abstract][Full Text] [Related]
6. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
7. IONA test for first-trimester detection of trisomies 21, 18 and 13.
Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G; Syngelaki A; Wang E; Struble C; Oliphant A; Song K; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):21-5. PubMed ID: 22996646
[TBL] [Abstract][Full Text] [Related]
10. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
11. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.
Canick JA; Kloza EM; Lambert-Messerlian GM; Haddow JE; Ehrich M; van den Boom D; Bombard AT; Deciu C; Palomaki GE
Prenat Diagn; 2012 Aug; 32(8):730-4. PubMed ID: 22585317
[TBL] [Abstract][Full Text] [Related]
12. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
13. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
Gil MM; Quezada MS; Bregant B; Ferraro M; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):34-40. PubMed ID: 23744609
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.
Dan S; Wang W; Ren J; Li Y; Hu H; Xu Z; Lau TK; Xie J; Zhao W; Huang H; Xie J; Sun L; Zhang X; Wang W; Liao S; Qiang R; Cao J; Zhang Q; Zhou Y; Zhu H; Zhong M; Guo Y; Lin L; Gao Z; Yao H; Zhang H; Zhao L; Jiang F; Chen F; Jiang H; Li S; Li Y; Wang J; Wang J; Duan T; Su Y; Zhang X
Prenat Diagn; 2012 Dec; 32(13):1225-32. PubMed ID: 23138752
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies.
Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):166-8. PubMed ID: 21570171
[TBL] [Abstract][Full Text] [Related]
18. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of total (maternal and fetal) beta-globin DNA in maternal blood from first trimester pregnancies with trisomy 21.
Jorgez CJ; Dang DD; Wapner R; Farina A; Simpson JL; Bischoff FZ
Hum Reprod; 2007 Aug; 22(8):2267-72. PubMed ID: 17584747
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R; Pérez Penco JM; Skyfta E; Rodríguez Calvo J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(2):72-7. PubMed ID: 20332643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
